Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term DNA Mutational Analysis. Found 13 abstracts

Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015 Dec 22;6(41):43594-604.   PMCID: PMC4791253
Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG. Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS ONE. 2008 Jan;3(10):e3533.   PMCID: PMC2568805
Karbowniczek M, Spittle CS, Morrison T, Wu H, Henske EP. mTOR is activated in the majority of malignant melanomas. The Journal of investigative dermatology. 2008 Apr;128(4):980-7.
Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92.   PMCID: PMC2448846
Pimkin M, Caretti E, Canutescu A, Yeung JB, Cohn H, Chen Y, Oleykowski C, Bellacosa A, Yeung AT. Recombinant nucleases CEL I from celery and SP I from spinach for mutation detection. BMC Biotechnol. 2007 Jan;7:29.   PMCID: PMC1896157
Spittle C, Ward MR, Nathanson KL, Gimotty PA, Rappaport E, Brose MS, Medina A, Letrero R, Herlyn M, Edwards RH. Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. The Journal of molecular diagnostics : JMD. 2007 Sep;9(4):464-71.
Chen X, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Review of Anticancer Therapy. 2006 Feb;6(2):187-96.
Robb VA, Astrinidis A, Henske EP. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.[erratum appears in Mod Pathol. 2006 Jun;19(6):889]. Modern Pathology. 2006 Jun;19(6):839-46.
Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients. Mod Pathol. 2002 Mar;15(3):205-10.
Apostolou S, Murthy SS, Kolachana P, Jhanwar SC, Testa JR. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer. Genes Chromosomes Cancer. 2001 Jan;30(1):96-8.
Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-90.
Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT. CEL I enzymatic mutation detection assay. Biotechniques. 2000 Jul;29(1):44-6, 48.
Sanchez-Cespedes M, Cairns P, Jen J, Sidransky D. Degenerate oligonucleotide-primed PCR (DOP-PCR): evaluation of its reliability for screening of genetic alterations in neoplasia. Biotechniques. 1998 Dec;25(6):1036-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term DNA Mutational Analysis

DNA Mutational Analysis genetics metabolism Human Non-US Gov't Support US Gov't Support-PHS methods Mutation Genetic Predisposition to Disease Polymerase Chain Reaction enzymology Neoplasm DNA Female analysis Cell Proliferation Protein Kinases Melanoma pathology Single Nucleotide Polymorphism Proto-Oncogene Proteins B-raf drug effects Endonucleases Male Sequence Deletion Tuberous Sclerosis NIH Research Support-Extramural Neoplasm Proteins Adult Point Mutation Repressor Proteins Tumor Cell Line Phosphorylation Risk Factors Signal Transduction pharmacology Lung Neoplasms BRCA1 Genes Ribosomal Protein S6 Protein Engineering 0 (BRCA1 Protein) Gene Frequency Post-Transcriptional RNA Processing Neuropeptides Proto-Oncogene Proteins c-kit Neoplasm RNA complications Sirolimus EC 3-6-5-2 (Monomeric GTP-Binding Proteins) US Gov't Research Support-Non-PHS Microsatellite Repeats Neoplastic Gene Expression Regulation Codon Molecular Sequence Data ge [Genetics] EC 2-7-1 (mTOR protein) Renal Cell Carcinoma In Situ Hybridization 1-Phosphatidylinositol 3-Kinase me [Metabolism] Kidney Neoplasms Software Smooth Muscle Gastrointestinal Stromal Tumors Colorectal Neoplasms Multiple Primary Neoplasms Pyrimidines Recombinant Proteins US Gov't Support-Non-PHS Case-Control Studies Hippel-Lindau Disease Cultured Tumor Cells Proto-Oncogene Proteins c-akt Antineoplastic Agents anal squamous cell carcinoma Proteins High-Throughput Nucleotide Sequencing Apoptosis Protein Kinase Inhibitors Ligases Introns Selection (Genetics) Biological) 0 (Tumor Markers BRCA1 Protein DNA Tumor Suppressor Genes Alleles Mesothelioma Hereditary Neoplastic Syndromes DNA Sequence Analysis Adolescence Acid Anhydride Hydrolases Clear Cell Adenocarcinoma Anus Neoplasms Platelet-Derived Growth Factor alpha Receptor an [Analysis] Heterozygote Paraffin Embedding Immunoenzyme Techniques Polymorphism (Genetics) Squamous Cell Carcinoma Enzyme Stability Satellite DNA Skin Neoplasms Spinacia oleracea Chromosome Disorders Lymphangioleiomyomatosis Gene Amplification Reproducibility of Results Middle Age Gene Expression Profiling Chromosome Aberrations Genotype chemistry Neoplasm) 0 (DNA 0 (Neuropeptides) Small Interfering RNA Nevus Lymphangiomyomatosis Tissue Fixation Non-US Gov't Research Support Breast Neoplasms IGF Type 1 Receptor Proto-Oncogene Proteins p21(ras) EC 2-7-1-137 (1-Phosphatidylinositol 3-Kinase) Polyacrylamide Gel Electrophoresis Transcriptome Oligonucleotide Array Sequence Analysis Immunohistochemistry Piperazines Single-Stranded Conformational Polymorphism Tumor Biomarkers Prostatic Neoplasms Genetic Screening standards Biological Tumor Markers 0 (Ribosomal Protein S6) Aged 70-kDa Ribosomal Protein S6 Kinases Mitogen-Activated Protein Kinase Kinases drug therapy Neoplasm Staging Kidney ph [Physiology] Neoplastic Cell Transformation therapeutic use antagonists & inhibitors 70-kDa) EC 2-7-1-37 (Ribosomal Protein S6 Kinases biomarker analysis Radiation Tolerance Child
Last updated on Wednesday, March 04, 2020